4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001415889-24-016518
Chief Executive Officer sold 5,000 shares at an average $17.65 ($88,264)
- Chief Executive Officer acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Townsend Richard Nolan Chief Executive Officer | 2024-06-10 | Option exercise 10b5-1 | +5,000 | $2.33 | $11,650 | 175,695 | D |
| Townsend Richard Nolan Chief Executive Officer | 2024-06-10 | Sale 10b5-1 | −2,962 | $17.29 | $51,213 | 172,733 | D |
| Townsend Richard Nolan Chief Executive Officer | 2024-06-10 | Sale 10b5-1 | −2,038 | $18.18 | $37,051 | 170,695 | D |
| Derivatives | |||||||
| Townsend Richard Nolan Chief Executive Officer | 2024-06-10 | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 143,655 | D | ||
| Open-market sales · 5,000 sh · avg $17.65 · $88,264 | |||||||
Loading xslF345X05/form4-06122024_050602.xml…